Emergence of community-acquired MRSA infections

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1306, 2001-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Community-acquired infections - the role of gatifloxacin

By  

Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Evaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections

By Sahloff Eric G   Close Sandy J   Martin Steven J  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 9, 2002-09 ,pp. : 1251-1266

Informa Healthcare

Access to resources Recommend Favorite

Clarithromycin extended-release in community-acquired respiratory tract infections

By Williams Kathy N   Bishai William R  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2867-2876

Informa Healthcare

Access to resources Recommend Favorite

Ceftriaxone: An Update of its Use in the Management of Community-Acquired and Nosocomial Infections

By Lamb H.M.   Ormrod D.   Scott L.J.   Figgitt D.P.  

Drugs, Vol. 62, Iss. 7, 2002-01 ,pp. : 1041-1089

Adis International

Access to resources Recommend Favorite

Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections

By Hammerschlag Margaret R   Sharma Roopali  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 387-400

Informa Healthcare

Access to resources Recommend Favorite